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The evaluation of research and doctoral training is being carried out in the years 2010–2012 and will end in 
2012. The steering group appointed by the Rector in January 2010 set the conditions for participating in 
the evaluation and prepared the Terms of Reference to present the evaluation procedure and criteria. The 
publications and other scientific activities included in the evaluation covered the years 2005–2010. 
The participating unit in the evaluation was defined as a Researcher Community (RC). To obtain a 
critical mass with university-level impact, the number of members was set to range from 20 to 120. The 
RCs were required to contain researchers in all stages of their research career, from doctoral students to 
principal investigators (PIs). All in all, 136 Researcher Communities participated in this voluntary 
evaluation, 5857 persons in total, of whom 1131 were principal investigators. PIs were allowed to 
participate in two communities in certain cases, and 72 of them used this opportunity and participated in 
two RCs. 
This evaluation enabled researchers to define RCs from the “bottom up” and across disciplines. The aim 
of the evaluation was not to assess individual performance but a community with shared aims and 
researcher-training activities. The RCs were able to choose among five different categories that 
characterised the status and main aims of their research. The steering group considered the process of 
applying to participate in the evaluation to be important, which lead to the establishment of these 
categories. In addition, providing a service for the RCs to enable them to benchmark their research at the 
global level was a main goal of the evaluation. 
The data for the evaluation consisted of the RCs’ answers to evaluation questions on supplied e-forms 
and a compilation extracted from the TUHAT – Research Information System (RIS) on 12 April 2011. The 
compilation covered scientific and other publications as well as certain areas of scientific activities. During 
the process, the RCs were asked to check the list of publications and other scientific activities and make 
corrections if needed. These TUHAT compilations are public and available on the evaluation project sites 
of each RC in the TUHAT-RIS. 
In addition to the e-form and TUHAT compilation, University of Leiden (CWTS) carried out bibliometric 
analyses from the articles included in the Web of Science (WoS). This was done on University and RC 
levels. In cases where the publication forums of the RC were clearly not represented by the WoS data, the 
Library of the University of Helsinki conducted a separate analysis of the publications. This was done for 
66 RCs representing the humanities and social sciences. 
The evaluation office also carried out an enquiry targeted to the supervisors and PhD candidates about 
the organisation of doctoral studies at the University of Helsinki. This and other documents describing the 
University and the Finnish higher education system were provided to the panellists. 
The panel feedback for each RC is unique and presented as an entity. The first collective evaluation 
reports available for the whole panel were prepared in July–August 2011. The reports were accessible to all 
panel members via the electronic evaluation platform in August. Scoring from 1 to 5 was used to 
complement written feedback in association with evaluation questions 1–4 (scientific focus and quality, 
doctoral training, societal impact, cooperation) and in addition to the category evaluating the fitness for 
participation in the evaluation. Panellists used the international level as a point of comparison in the 
evaluation. Scoring was not expected to go along with a preset deviation. 
Each of the draft reports were discussed and dealt with by the panel in meetings in Helsinki (from 11 
September to 13 September or from 18 September to 20 September 2011). In these meetings the panels 
also examined the deviations among the scores and finalised the draft reports together. 
The current RC-specific report deals shortly with the background of the evaluation and the terms of 
participation. The main evaluation feedback is provided in the evaluation report, organised according to 











On behalf of the evaluation steering group and office, I sincerely wish to thank you warmly for your 
participation in this evaluation. The effort you made in submitting the data to TUHAT-RIS is gratefully 
acknowledged by the University. We wish that you find this panel feedback useful in many ways. The 
bibliometric profiles may open a new view on your publication forums and provide a perspective for 
discussion on your choice of forums. We especially hope that this evaluation report will help you in setting 
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1 Introduction to the Evaluation 
1.1 RC-specific evaluation reports 
The participants in the evaluation of research and doctoral training were Researcher Communities 
(hereafter referred to as the RC). The RC refers to the group of researchers who registered together in the 
evaluation of their research and doctoral training. Preconditions in forming RCs were stated in the 
Guidelines for the Participating Researcher Communities. The RCs defined themselves whether their 
compositions should be considered well-established or new. 
It is essential to emphasise that the evaluation combines both meta-evaluation1 and traditional 
research assessment exercise and its focus is both on the research outcomes and procedures associated 
with research and doctoral training. The approach to the evaluation is enhancement-led where self-
evaluation constituted the main information. The answers to the evaluation questions formed together 
with the information of publications and other scientific activities an entity that was to be reviewed as a 
whole. 
The present evaluation recognizes and justifies the diversity of research practices and publication 
traditions. Traditional Research Assessment Exercises do not necessarily value high quality research with 
low volumes or research distinct from mainstream research. It is challenging to expose the diversity of 
research to fair comparison. To understand the essence of different research practices and to do justice to 
their diversity was one of the main challenges of the present evaluation method. Understanding the 
divergent starting points of the RCs demanded sensitivity from the evaluators. 
1.2 Aims and objectives in the evaluation 
The aims of the evaluation are as follows: 
 to improve the level of research and doctoral training at the University of Helsinki and to raise 
their international profile in accordance with the University’s strategic policies. The improvement 
of doctoral training should be compared to the University’s policy.2 
 to enhance the research conducted at the University by taking into account the diversity, 
originality, multidisciplinary nature, success and field-specificity, 
 to recognize the conditions and prerequisites under which excellent, original and high-impact 
research is carried out, 
 to offer the academic community the opportunity to receive topical and versatile international 
peer feedback, 
 to better recognize the University’s research potential. 
 to exploit the University’s TUHAT research information system to enable transparency of 
publishing activities and in the production of reliable, comparable data. 
1.3 Evaluation method 
The evaluation can be considered as an enhancement-led evaluation. Instead of ranking, the main aim is to 
provide useful information for the enhancement of research and doctoral training of the participating RCs. 
The comparison should take into account each field of science and acknowledge their special character. 
                                                                
1 The panellists did not read research reports or abstracts but instead, they evaluated answers to the evaluation 
questions, tables and compilations of publications, other scientific activities, bibliometrics or comparable analyses. 
2
 Policies on doctoral degrees and other postgraduate degrees at the University of Helsinki.  
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The comparison produced information about the present status and factors that have lead to success. Also 
challenges in the operations and outcomes were recognized. 
The evaluation approach has been designed to recognize better the significance and specific nature of 
researcher communities and research areas in the multidisciplinary top-level university. Furthermore, one 
of the aims of the evaluation is to bring to light those evaluation aspects that differ from the prevalent 
ones. Thus the views of various fields of research can be described and research arising from various 
starting points understood better. The doctoral training is integrated into the evaluation as a natural 
component related to research. Operational processes of doctoral training are being examined in the 
evaluation. 
 
Five stages of the evaluation method were: 
1. Registration – Stage 1 
2. Self-evaluation – Stage 2 
3. TUHAT3 compilations on publications and other scientific activities4 
4. External evaluation 
5. Public reporting 
1.4 Implementation of the external evaluation 
Five Evaluation Panels 
Five evaluation panels consisted of independent, renowned and highly respected experts. The main 
domains of the panels are: 
1. biological, agricultural and veterinary sciences 
2. medicine, biomedicine and health sciences 
3. natural sciences 
4. humanities 
5. social sciences 
The University invited 10 renowned scientists to act as chairs or vice-chairs of the five panels based on 
the suggestions of faculties and independent institutes. Besides leading the work of the panel, an 
additional role of the chairs was to discuss with other panel chairs in order to adopt a broadly similar 
approach. The panel chairs and vice-chairs had a pre-meeting on 27 May 2011 in Amsterdam. 
The panel compositions were nominated by the Rector of the University 27 April 2011. The participating 
RCs suggested the panel members. The total number of panel members was 50. The reason for a smaller 
number of panellists as compared to the previous evaluations was the character of the evaluation as a 
meta-evaluation. The panellists did not read research reports or abstracts but instead, they evaluated 
answers to the evaluation questions, tables and compilations of publications, other scientific activities, 
bibliometrics and comparable analyses. 
 
The panel meetings were held in Helsinki: 
 On 11–13 September 2011: (1) biological, agricultural and veterinary sciences, (2) medicine, 
biomedicine and health sciences and (3) natural sciences.  
 On 18–20 September 2011: (4) humanities and (5) social sciences. 
  
                                                                
3 TUHAT (acronym) of Research Information System (RIS) of the University of Helsinki 
4 Supervision of thesis, prizes and awards, editorial work and peer reviews, participation in committees, boards and 





1.5 Evaluation material 
The main material in the evaluation was the RCs’ self-evaluations that were qualitative in character and 
allowed the RCs to choose what was important to mention or emphasise and what was left unmentioned. 
The present evaluation is exceptional at least in the Finnish context because it is based on both the 
evaluation documentation (self-evaluation questions, publications and other scientific activities) and the 
bibliometric reports. All documents were delivered to the panellists for examination. 
Traditional bibliometrics can be reasonably done mainly in medicine, biosciences and natural sciences 
when using the Web of Science database, for example. Bibliometrics, provided by CWTS/The Centre for 
Science and Technology Studies, University of Leiden, cover only the publications that include WoS 
identification in the TUHAT-RIS. 
Traditional bibliometrics are seldom relevant in humanities and social sciences because the 
international comparable databases do not store every type of high quality research publications, such as 
books and monographs and scientific journals in other languages than English. The Helsinki University 
Library has done analysis to the RCs, if their publications were not well represented in the Web of Science 
databases (RCs should have at least 50 publications and internal coverage of publications more than 40%) 
– it meant 58 RCs. The bibliometric material for the evaluation panels was available in June 2011. The RC-
specific bibliometric reports are attached at the end of each report. 
The panels were provided with the evaluation material and all other necessary background information, 
such as the basic information about the University of Helsinki and the Finnish higher education system. 
 
Evaluation material 
1. Registration documents of the RCs for the background information 
2. Self evaluation material – answers to the evaluation questions 
3. Publications and other scientific activities based on the TUHAT RIS: 
3.1. statistics of publications 
3.2. list of publications 
3.3. statistics of other scientific activities 
3.4. list of other scientific activities 
4. Bibliometrics and comparable analyses: 
4.1. Analyses of publications based on the verification of TUHAT-RIS publications with the Web 
of Science publications (CWTS/University of Leiden) 
4.2. Publication statistics analysed by the Helsinki University Library - mainly for humanities and 
social sciences 
5. University level survey on doctoral training (August 2011) 





University of Helsinki 
- Basic information about the University of the Helsinki 
- The structure of doctoral training at the University of Helsinki 
- Previous evaluations of research at the University of Helsinki – links to the reports: 1998 and 2005 
 
The Finnish Universities/Research Institutes 
- Finnish University system 
- Evaluation of the Finnish National Innovation System 
- The State and Quality of Scientific Research in Finland. Publication of the Academy of Finland 
9/09. 
 




1.6 Evaluation questions and material 
The participating RCs answered the following evaluation questions which are presented according to the 
evaluation form. In addition, TUHAT RIS was used to provide the additional material as explained. For 
giving the feedback to the RCs, the panellists received the evaluation feedback form constructed in line 
with the evaluation questions: 
 
1. Focus and quality of the RC’s research 
 Description of 
- the RC’s research focus. 
- the quality of the RC’s research (incl. key research questions and results) 
- the scientific significance of the RC’s research in the research field(s) 
 Identification of the ways to strengthen the focus and improve the quality of the RC’s research 
The additional material: TUHAT compilation of the RC’s publications, analysis of the RC’s publications data 
(provided by University of Leiden and the Helsinki University Library) 
A written feedback from the aspects of: scientific quality, scientific significance, societal impact, 
innovativeness 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
2. Practises and quality of doctoral training 
 Organising of the doctoral training in the RC. Description of the RC’s principles for: 
- recruitment and selection of doctoral candidates 
- supervision of doctoral candidates 
- collaboration with faculties, departments/institutes, and potential graduate schools/doctoral 
programmes 
- good practises and quality assurance in doctoral training 
- assuring of good career perspectives for the doctoral candidates/fresh doctorates 
 Identification of the RC’s strengths and challenges related to the practises and quality of doctoral 
training, and the actions planned for their development. 
The additional material: TUHAT compilation of the RC’s other scientific activities/supervision of doctoral 
dissertations 
A written feedback from the aspects of: processes and good practices related to leadership and 
management 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
3. The societal impact of research and doctoral training 
 Description on how the RC interacts with and contributes to the society (collaboration with 
public, private and/or 3rd sector). 
 Identification of the ways to strengthen the societal impact of the RC’s research and doctoral 
training. 
The additional material: TUHAT compilation of the RC’s other scientific activities. 
A written feedback from the aspects of: societal impact, national and international collaboration, 
innovativeness 
 
  Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 







4. International and national (incl. intersectoral) research collaboration and researcher mobility 
 Description of  
- the RC’s research collaborations and joint doctoral training activities 
- how the RC has promoted researcher mobility 
 Identification of the RC’s strengths and challenges related to research collaboration and 
researcher mobility, and the actions planned for their development. 
A written feedback from the aspects of: scientific quality, national and international collaboration 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
5. Operational conditions  
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties). 
 Identification of the RC’s strengths and challenges related to operational conditions, and the 
actions planned for their development. 
A written feedback from the aspects of: processes and good practices related to leadership and 
management 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
6. Leadership and management in the researcher community 
 Description of 
- the execution and processes of leadership in the RC 
- how the management-related responsibilities and roles are distributed in the RC 
- how the leadership- and management-related processes support 
- high quality research 
- collaboration between principal investigators and other researchers in the RC 
the RC’s research focus 
- strengthening of the RC’s know-how 
 Identification of the RC’s strengths and challenges related to leadership and management, and 
the actions planned for developing the processes 
 
7. External competitive funding of the RC 
 The RCs were asked to provide information of such external competitive funding, where: 
- the funding decisions have been made during 1.1.2005-31.12.2010, and 
- the administrator of the funding is/has been the University of Helsinki 
 On the e-form the RCs were asked to provide: 
1) The relevant funding source(s) from a given list (Academy of Finland/Research Council, TEKES/The 
Finnish Funding Agency for Technology and Innovation , EU, ERC, foundations, other national funding 
organisations, other international funding organisations), and 
2)The total sum of funding which the organisation in question had decided to allocate to the RCs 
members during 1.1.2005–31.12.2010. 
 
Competitive funding reported in the text is also to be considered when evaluating this point. 
A written feedback from the aspects of: scientific quality, scientific significance, societal impact, 
innovativeness, future significance 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
8. The RC’s strategic action plan for 2011–2013 
 RC’s description of their future perspectives in relation to research and doctoral training. 
A written feedback from the aspects of: scientific quality, scientific significance, societal Impact, processes 
and good practices related to leadership and management, national and international collaboration, 
innovativeness, future significance 
 Strengths 
 Areas of development 
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 Other remarks 
 Recommendations 
 
9. Evaluation of the category of the RC in the context of entity of the evaluation material (1-8) 
 
The RC’s fitness to the chosen participation category 
A written feedback evaluating the RC’s fitness to the chosen participation category  
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
10. Short description of how the RC members contributed the compilation of the stage 2 material 
Comments on the compilation of evaluation material 
 
11. How the UH’s focus areas are presented in the RC’s research? 
Comments if applicable 
 
12. RC-specific main recommendations based on the previous questions 1–11 
 
13. RC-specific conclusions 
1.7 Evaluation criteria 
The panellists were expected to give evaluative and analytical feedback to each evaluation question 
according to their aspects in order to describe and justify the quality of the submitted material. In 
addition, the evaluation feedback was asked to be pointed out the level of the performance according to 
the following classifications: 
 outstanding  (5) 
 excellent  (4) 
 very good  (3) 
 good   (2) 
 sufficient  (1) 
 
Evaluation according to the criteria was to be made with thorough consideration of the entire 
evaluation material of the RC in question. Finally, in questions 1-4 and 9, the panellists were expected to 
classify their written feedback into one of the provided levels (the levels included respective descriptions, 
‘criteria’). Some panels used decimals in marks. The descriptive level was interpreted according to the 
integers and not rounding up the decimals by the editors. 
 
Description of criteria levels 
Question 1 – FOCUS AND QUALITY OF THE RC’S RESEARCH 
 
Classification: Criteria (level of procedures and results) 
Outstanding quality of procedures and results (5) 
Outstandingly strong research, also from international perspective. Attracts great international 
interest with a wide impact, including publications in leading journals and/or monographs published 
by leading international publishing houses. The research has world leading qualities. The research 
focus, key research questions scientific significance, societal impact and innovativeness are of 
outstanding quality. 
In cases where the research is of a national character and, in the judgement of the evaluators, should 
remain so, the concepts of ”international attention” or ”international impact” etc. in the grading 





Operations and procedures are of outstanding quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are in 
alignment with the documentation. The ambition to develop the community together is of 
outstanding quality. 
Excellent quality of procedures and results (4) 
Research of excellent quality. Typically published with great impact, also internationally. Without 
doubt, the research has a leading position in its field in Finland. 
Operations and procedures are of excellent quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are to 
large extent in alignment with the documentation. The ambition to develop the community together 
is of excellent quality. 
Very good quality of procedures and results (3) 
The research is of such very good quality that it attracts wide national and international attention. 
Operations and procedures are of very good quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are to 
large extent in alignment with the documentation. The ambition to develop the community together 
is of very good quality. 
Good quality of procedures and results (2) 
Good research attracting mainly national attention but possessing international potential, 
extraordinarily high relevance may motivate good research. 
Operations and procedures are of good quality, shared occasionally in the community. The 
improvement of research and other efforts are occasionally documented and operations and 
practices are to large extent in alignment with the documentation. The ambition to develop the 
community together is of good quality. 
Sufficient quality of procedures and results (1) 
In some cases the research is insufficient and reports do not gain wide circulation or do not have 
national or international attention. Research activities should be revised. 
Operations and procedures are of sufficient quality, shared occasionally in the community. The 
improvement of research and other efforts are occasionally documented and operations and 
practices are to some extent in alignment with the documentation. The ambition to develop the 
community together is of sufficient quality. 
 
Question 2 – DOCTORAL TRAINING 
Question 3 – SOCIETAL IMPACT 
Question 4 – COLLABORATION 
 
Classification: Criteria (level of procedures and results) 
Outstanding quality of procedures and results (5) 
Procedures are of outstanding quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are in alignment with the 
documentation. The ambition to develop the community together is of outstanding quality. The 
procedures and results are regularly evaluated and the feedback has an effect on the planning. 
Excellent quality of procedures and results (4) 
Procedures are of excellent quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of excellent quality. The 
procedures and outcomes are evaluated and the feedback has an effect on the planning. 
Very good quality of procedures and results (3) 
Procedures are of very good quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
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management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of very good quality. 
Good quality of procedures and results (2) 
Procedures are of good quality, shared occasionally in the community. The practices and quality of 
doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of good quality. 
Sufficient quality of procedures and results (1) 
Procedures are of sufficient quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are occasionally documented and operations and practices are to some extent in 
alignment with the documentation. The ambition to develop the community together is of sufficient 
quality. 
 
Question 9 – CATEGORY 
Participation category – fitness for the category chosen 
The choice and justification for the chosen category below should be reflected in the RC’s responses to the 
evaluation questions 1–8. 
1. The research of the participating community represents the international cutting edge in its field. 
2. The research of the participating community is of high quality, but the community in its present 
composition has yet to achieve strong international recognition or a clear break-through. 
3. The research of the participating community is distinct from mainstream research, and the special 
features of the research tradition in the field must be considered in the evaluation. The research is 
of high quality and has great significance and impact in its field. However, the generally used 
research evaluation methods do not necessarily shed sufficient light on the merits of the 
research.  
4. The research of the participating community represents an innovative opening. A new opening can 
be an innovative combination of research fields, or it can be proven to have a special social, 
national or international demand or other significance. Even if the researcher community in its 
present composition has yet to obtain proof of international success, its members can produce 
convincing evidence of the high level of their previous research. 
5. The research of the participating community has a highly significant societal impact. The 
participating researcher community is able to justify the high social significance of its research. 
The research may relate to national legislation, media visibility or participation in social debate, 
or other activities promoting social development and human welfare. In addition to having 
societal impact, the research must be of a high standard. 
 
An example of outstanding fitness for category choice (5) 5 
The RC’s representation and argumentation for the chosen category were convincing. The RC recognized 
its real capacity and apparent outcomes in a wider context to the research communities. The specific 
character of the RC was well-recognized and well stated in the responses. The RC fitted optimally for the 
category. 
 
 Outstanding  (5) 
 Excellent  (4) 
 Very good  (3) 
 Good   (2) 
 Sufficient  (1) 
The above-mentioned definition of outstanding was only an example in order to assist the panellists in 
the positioning of the classification. There was no exact definition for the category fitness. 
                                                                





1.8 Timetable of the evaluation 
The main timetable of the evaluation: 
1. Registration   November 2010 
2. Submission of self-evaluation materials  January–February 2011 
3. External peer review    May–September 2011 
4. Published reports    March–April 2012 
- University level public report 
- RC specific reports 
 
The entire evaluation was implemented during the university’s strategy period 2010–2012. The preliminary 
results were available for the planning of the following strategy period in late autumn 2011. The evaluation 
reports will be published in March/April 2012. More detailed time schedule is published in the University 
report. 
1.9 Evaluation feedback – consensus of the entire panel 
The panellists evaluated all the RC-specific material before the meetings in Helsinki and mailed the 
draft reports to the evaluation office. The latest interim versions were on-line available to all the panellists 
on the Wiki-sites. In September 2011, in Helsinki the panels discussed the material, revised the first draft 
reports and decided the final numeric evaluation. After the meetings in Helsinki, the panels continued 
working and finalised the reports before the end of November 2011. The final RC-specific reports are the 
consensus of the entire panel. 
The evaluation reports were written by the panels independently. During the editing process, the 
evaluation office requested some clarifications from the panels when necessary. The tone and style in the 
reports were not harmonized in the editing process. All the reports follow the original texts written by the 
panels as far as it was possible. 
The original evaluation material of the RCs, provided for the panellists is attached at the end of the 
report. It is essential to notice that the exported lists of publications and other scientific activities depend 









2 Evaluation feedback 
2.1 Focus and quality of the RC’s research 
 Description of 
 the RC’s research focus 
 the quality of the RC’s research (incl. key research questions and results) 
 the scientific significance of the RC’s research in the research field(s) 
 Identification of the ways to strengthen the focus and improve the quality of the RC’s research 
ASPECTS: Scientific quality, scientific significance, societal impact, innovativeness 
 
The RC represents the research and doctoral training done at the Department of Obstetrics and 
Gynecology and by Markus Heikinheimo from the Department of Pediatrics in Helsinki University. The 
strengths of the RC are in HPV, Chlamydia, genetics and cancer research related to women’s health. The 
problem with this RC is that it does not have a clear focus but it covers all the research and doctoral 
training done in the Department of Obstetrics and Gynecology. The RC has a good production of scientific 
articles and some in excellent journals like Nature, Nature Genetics, Lancet, NEJM which shows potential 
excellence in this RC. The material provided in RC-spesific stage 2 is quite thin compared with other RCs 
and it was even impossible to find out that Prof. Markus Heikinheimo is a director of the National Graduate 
Programme of Clinical Sciences and Docent Aila Tiitinen is the steering committee which actually shows 
that the RC has merits in doctoral training. The RC led by two almost emeritus professors is not the best 
choice for the future. Younger group leaders should have been more involved in the compilation of the 
material for the evaluation. 
Recommendation for the RC is that it should try to focus the research and let the younger group 
leaders show their insights in the research and doctoral training which they most likely have done but it is 
not obvious in the material provided for the panel. 
Numeric evaluation: 3 (Very good) 
2.2 Practises and quality of doctoral training 
 Organising of the doctoral training in the RC. Description of the RC’s principles for: 
 recruitment and selection of doctoral candidates 
 supervision of doctoral candidates 
 collaboration with faculties, departments/institutes, and potential graduate schools/doctoral 
programmes 
 good practises and quality assurance in doctoral training 
 assuring of good career perspectives for the doctoral candidates/fresh doctorates 
 Identification of the RC’s strengths and challenges related to the practises and quality of doctoral 
training, and the actions planned for their development. 
 Additional material: TUHAT compilation of the RC’s other scientific activities/supervision of doctoral 
dissertations 
ASPECTS: Processes and good practices related to leadership and management 
 
The RC has produced enough MD/PhDs and as stated before, Prof. Markus Heikinheimo is a director of 
national doctoral programme in clinical sciences, which is an important position in the development of 
doctoral training in clinical sciences. Clinical MD/PhD training has nowadays many more obstacles than 
before. To have a MD/PhD as such is not always the merit as it used to be even in the University Hospitals. 
It is very challenging to have MD/PhD training and specialization at the same time, and this clearly is the 
important area to develop further. The funding for MD/PhD should not be a problem due to EVO funding, 
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which should be directed to excellent research and doctoral training. Ear-marked funding from the 
Ministry of Culture and Education and Academy of Finland to the national doctoral programme of clinical 
sciences should be continued. 
Numeric evaluation: 4 (Excellent) 
2.3 The societal impact of research and doctoral training 
 Description on how the RC interacts with and contributes to the society (collaboration with public, 
private and/or 3rd sector). 
 Identification of the ways to strengthen the societal impact of the RC’s research and doctoral training. 
 Additional material: TUHAT compilation of the RC’s other scientific activities. 
ASPECTS: Societal impact, national and international collaboration, innovativeness 
 
The RC is satisfied and comfortable with the current situation which is most likely not true. HPV 
vaccination, cancer screening and findings of the importance BRCA1/2 genes in breast cancer are of 
importance but when the RC states that it is not the RC’s highest priority it is difficult to see the future of 
this RC. 
Recommendation: Let the young group leaders show their views. 
Numeric evaluation: 3 (Very good) 
2.4 International and national (incl. intersectoral) research 
collaboration and researcher mobility 
 Description of  
 the RC’s research collaborations and joint doctoral training activities 
 how the RC has promoted researcher mobility 
 Identification of the RC’s strengths and challenges related to research collaboration and researcher 
mobility, and the actions planned for their development. 
ASPECTS: Scientific quality, national and international collaboration 
 
The RC has excellent international and national collaboration in HPV and Chlamydia research and also in 
cancer genetics, which are also seen in cutting edge publications such as Lancet, NEJM and Nature 
Genetics. 
Numeric evaluation: 4 (Excellent) 
2.5 Operational conditions 
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties). 
 Identification of the RC’s strengths and challenges related to operational conditions, and the actions 
planned for their development. 
ASPECTS: Processes and good practices related to leadership and management 
 
The description of the RC provided by Prof. Jorma Paavonen is very traditional in a clinical department in 
the university hospital but does not seem to observe the future challenges and views how to improve 






2.6 Leadership and management in the researcher community 
 Description of  
 the execution and processes of leadership in the RC 
 how the management-related responsibilities and roles are distributed in the RC 
 how the leadership- and management-related processes support 
 high quality research 
 collaboration between principal investigators and other researchers in the RC 
 the RC’s research focus 
 strengthening of the RC’s know-how 
 Identification of the RC’s strengths and challenges related to leadership and management, and the 
actions planned for developing the processes 
ASPECTS: Processes and good practices related to leadership and management 
 
The RC is too much led by the older professors and younger group leaders should have more to state how 
they would lead the department in the future. The statement that OB/GYN department is the biggest in 
Europe should also mean that leadership and management would be more challenging than described in a 
few lines outlined in the material. 
2.7 External competitive funding of the RC 
• The RCs were asked to provide information of such external competitive funding, where: 
• the funding decisions have been made during 1.1.2005–31.12.2010, and  
• the administrator of the funding is/has been the University of Helsinki 
• On the e-form the RCs were asked to provide: 
1) The relevant funding source(s) from a given list (Academy of Finland/Research Council, 
TEKES/The Finnish Funding Agency for Technology and Innovation, EU, ERC, foundations, other 
national funding organisations, other international funding organizations), and 
2) The total sum of funding which the organisation in question had decided to allocate to the RCs 
members during 1.1.2005–31.12.2010. 
Competitive funding reported in the text is also to be considered when evaluating this point. 
ASPECTS: Scientific quality, scientific significance, societal impact, innovativeness and future significance 
 
The RC gets most of their funding from EVO and the Academy of Finland which is at an excellent level and 
shows the importance of this RC. 
2.8 The RC’s strategic action plan for 2011–2013 
• RC’s description of their future perspectives in relation to research and doctoral training. 
ASPECTS: Scientific quality, scientific significance, societal Impact, processes and good practices related to 
leadership and management, national and international collaboration, innovativeness, future significance 
 
With a few words the RC states clearly that the first priority is to increase scientific productivity and that 
the number of residents in doctoral training is increasing. 





2.9 Evaluation of the category of the RC in the context of entity of 
the evaluation material (1-8) 
The RC’s fitness to the chosen participation category. 
Category 2. The research of the participating community is of high quality, but the community in its present 
composition has yet to achieve strong international recognition or a clear break-through. 
 
The RC fits within the chosen category. 
Numeric evaluation: 3 (Very good) 
2.10 Short description of how the RC members contributed the 
compilation of the stage 2 material 
The compilation of the material was clearly done only by Prof. Jorma Paavonen. 
2.11 How the UH’s focus areas are presented in the RC’s research 
Focus area 6: Clinical research 
2.12 RC-specific main recommendations 
Recommendations: 
1. Try to focus on the research 
2. Let the young group leaders have more influence on strategic actions and evaluations like this. 
2.13 RC-specific conclusions 
The RC describes all the research and doctoral training done at the Department of Obstetrics and 
Gynecology without any clear focus of the research or doctoral training. Some results are excellent, but 
better description and further actions are missed in the material compiled only by the director of the RC. 
Very excellent in this RC is that there are young group leaders like Heikinheimos, Markus and Oskari. Prof. 
Markus Heikinheimo has an important position to lead and direct the national doctoral programme of 
clinical sciences. The material provided for the evaluators was not compiled in a most successful way and 
hopefully in the future the young group leaders would take more responsibility that their own views of the 
research and doctoral training are properly presented for the evaluators. 
2.14 Preliminary findings in the University-level evaluation 
The RC should have more focus, and the younger group leaders should have shown their own views about 
the future of the research and doctoral training. Partly excellent results are not properly presented in the 
evaluation material. Leadership and management and strategic action plan are not really described such a 
way to taken seriously. The RC has excellent funding and excellent production of articles and PhDs. 
Some of the papers have been published in cutting edge journals like Nature, Nature Genetics, Lancet 







A. Original evaluation material 
a. Registration material – Stage 1 
b. Answers to evaluation questions – Stage 2 
c. List of publications 
d. List of other scientific activities 
B. Bibliometric analyses 
a. Analysis provided by CWTS/University of Leiden 






International evaluation of research and doctoral training 
at the University of Helsinki 2005-2010 
 





NAME OF THE RESEARCHER COMMUNITY:  
Women’s Health Research Program (Women’s Health) 
 
LEADER OF THE RESEARCHER COMMUNITY:  
Professor Jorma Paavonen, Institute of Clinical Medicine, Faculty of Medicine 
 
 
RC-SPECIFIC MATERIAL FOR THE PEER REVIEW: 
 Material submitted by the RC at stages 1 and 2 of the evaluation 
- STAGE 1 material: RC’s registration form (incl. list of RC participants in an excel table) 
- STAGE 2 material: RC’s answers to evaluation questions 
 TUHAT compilations of the RC members’ publications 1.1.2005-31.12.2010 
 TUHAT compilations of the RC members’ other scientific activities 1.1.2005-31.12.2010 
 Web of Science(WoS)-based bibliometrics of the RC’s publications data 1.1.2005-31.12.2010 
(analysis carried out by CWTS, Leiden University) 
NB! Since Web of Science(WoS)-based bibliometrics does not provide representative results for most RCs representing 
humanities, social sciences and computer sciences, the publications of these RCs will be analyzed by the UH Library 
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Name: Paavonen, Jorma 
E-mail:  
Phone: +358-50-427 2060 
Affiliation: Institute of Clinical Medicine, Department of Obstetrics and Gynecology 
Street address: Haartmaninkatu 2, 00290 Helsinki 
 
 
Name of the participating RC (max. 30 characters): Women's Health Research Program 
Acronym for the participating RC (max. 10 characters): Women's Health 
Description of the operational basis in 2005-2010 (eg. research collaboration, joint doctoral training 
activities) on which the RC was formed (MAX. 2200 characters with spaces): Research on women’s health 
has evolved and expanded during recent years. This research program envolves a large research 
consortium. Our department is the largest department of obstetrics and gynecology in Europe with 
approximately 15 000 deliveries and 150 000 outpatient visits/year. The strengths of the program include 
huge base for clinical patient-oriented research, unique biobanks, utilization of health registry networks 
and integration of translational and basic research. 
 
 
Main scientific field of the RC’s research: medicine, biomedicine and healt sciences 
RC's scientific subfield 1: Obstetrics and Gynecology 
RC's scientific subfield 2: --Select-- 
RC's scientific subfield 3: --Select-- 
RC's scientific subfield 4: --Select-- 
Other, if not in the list:  
 
 
Participation category: 2. Research of the participating community is of high quality, but the community in 
its present composition has yet to achieve strong international recognition or a clear break-through 
Justification for the selected participation category (MAX. 2200 characters with spaces):  We feel that 
physician-scientist is endangered and threathened species since it has been increasingly difficult to recruit 
and retain physician-scientists to maintain academic medicine in frontline and to build better career 
pipelines. Our goal is to meet these major challenges by producing high impact research in general and 
specifically high impact clinical research in women’s health. The unique perspective physician-scientists 
1 RESPONSIBLE PERSON 
2 DESCRIPTION OF THE PARTICIPATING RESEARCHER COMMUNITY (RC) 
3 SCIENTIFIC FIELDS OF THE RC 
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UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC STAGE 1 MATERIAL (registration form) 
 
 
bring to medical research is that scientific questions arise in the clinic at the bed-side. Overall, we are 
convinced that our productivity has been strikingly high and of extremely high quality. This justifies us to 
look for international recognition and appreciation through evaluation. This is particularly important since 




Public description of the RC's research and doctoral training (MAX. 2200 characters with spaces): We are 
training large number of graduate students and postdoctoral fellows who will then become trained 
scientists in the fields of women’s health research including infection, reproduction, tumours, and genetics. 
Significance of the RC's research and doctoral training for the University of Helsinki (MAX. 2200 
characters with spaces): We are training large number of graduate students and postdoctoral fellows who 
will then become trained scientists in the fields of women’s health research including infection, 
reproduction, tumours, and genetics. 
Keywords: Women’s health, infection and inflammation, cervical screening, reproduction, menopausal 
physiology, ovarian cancer, breast cancer, pregnancy and genes 
 
 
Justified estimate of the quality of the RC's research and doctoral training at national and international 
level during 2005-2010 (MAX. 2200 characters with spaces): We have included a complete list of 
publications representing the time period under evaluation (TUHAT). We also provide h-indexes of principal 
investigators to justify the quality of the research training at national and international levels (Web of 
Science). 
Comments on how the RC's scientific productivity and doctoral training should be evaluated (MAX. 2200 
characters with spaces): We have included a complete list of publications representing the time period 
under evaluation (TUHAT). We also provide h-indexes of principal investigators to justify the quality of the 
research training at national and international levels (Web of Science). 
5 DESCRIPTION OF THE RC'S RESEARCH AND DOCTORAL TRAINING 
6 QUALITY OF RC'S RESEARCH AND DOCTORAL TRAINING 
LIST OF RC MEMBERS
NAME OF THE RESEARCHER COMMUNITY: Women's Health Research Program
RC-LEADER J. Paavonen
CATEGORY 2





Title of research and 
teaching personnel Affiliation 
1 Paavonen Jorma x IV Professor UH, Faculty of Medicine
2 Butzow Ralf III Senior researcher UH, Faculty of Medicine
3 Heikinheimo Markku x IV Professor UH, Faculty of Medicine
4 Heikinheimo Oskari x III Senior researcher UH, Faculty of Medicine
5 Laivuori Hannele x III Senior researcher UH, Faculty of Medicine
6 Mikkola Tomi x III Senior researcher UH, Faculty of Medicine
7 Nevanlinna Heli x III Senior researcher UH, Faculty of Medicine
8 Nieminen Pekka x III Senior researcher UH, Faculty of Medicine
9 Tiitinen Aila x IV Professor UH, Faculty of Medicine
10 Ylikorkala Olavi x IV Professor UH, Faculty of Medicine
11 Andersson Noora II Postdoctoral researcher UH, Faculty of Medicine
12 Anttila Ahti III Senior researcher Finnish Cancer Registry
13 Anttonen Mikko II Postdoctoral researcher UH, Faculty of Medicine
14 Apter Dan III Senior researcher Family Federation of Finland
15 Gissler Mika III Senior researcher National Institute of Health and Welfare
16 Heino Sanna II Postdoctoral researcher UH, Faculty of Medicine
17 Hurskainen Ritva III Senior researcher UH, Faculty of Medicine
18 Joki-Korpela Päivi II Postdoctoral researcher UH, Faculty of Medicine
19 Lassus Heini II Postdoctoral researcher UH, Faculty of Medicine
20 Leminen Arto x III Senior researcher UH, Faculty of Medicine
21 Loukovaara Mikko III Senior researcher UH, Faculty of Medicine
22 Lyytinen Heli II Postdoctoral researcher UH, Faculty of Medicine
23 Niinimäki Maarit II Postdoctoral researcher University of Oulu
24 Puolakkainen Mirja x III Senior researcher HU, Faculty of Medicine
25 Salonen Jonna II Postdoctoral researcher UH, Faculty of Medicine
26 Savolainen-Peltonen Hanna III Senior researcher HU, Faculty of Medicine
27 Suhonen Satu III Senior researcher Helsinki City Hospital
28 Tikkanen Minna III Senior researcher UH, Faculty of Medicine
29 Tuomikoski Pauliina II Postdoctoral researcher UH, Faculty of Medicine
30 Ulander Veli-Matti III Senior researcher UH, Faculty of Medicine
31 Unkila-Kallio Leila III Senior researcher UH, Faculty of Medicine
32 Väisänen-Tommiska Mervi III Senior researcher UH, Faculty of Medicine
33 Aalto-Viljakainen Tia I Doctoral candidate UH, Faculty of Medicine
34 Färkkilä Anniina I Doctoral candidate UH, Faculty of Medicine
35 Haltia Ulla-Maija I Doctoral candidate UH, Faculty of Medicine
36 Hautamäki Hanna I Doctoral candidate UH, Faculty of Medicine
37 Heikkinen Tuomas I Doctoral candidate UH, Faculty of Medicine
38 Hoikkala Hanna I Doctoral candidate UH, Faculty of Medicine
39 Hyden-Granskog Christel I Doctoral candidate UH, Faculty of Medicine
40 Kaislasuo Janina I Doctoral candidate UH, Faculty of Medicine
41 Kalliala Ilkka I Doctoral candidate UH, Faculty of Medicine
42 Kauppinen Marjut I Doctoral candidate UH, Faculty of Medicine
43 Koivisto-Korander Riitta I Doctoral candidate UH, Faculty of Medicine
44 Koskela-Koivisto Tiina I Doctoral candidate UH, Faculty of Medicine
45 Kuronen Elina I Doctoral candidate UH, Faculty of Medicine
46 Kyrönlahti Antti I Doctoral candidate UH, Faculty of Medicine
47 Leinonen Maarit I Doctoral candidate Finnish Cancer Registry
48 Leminen Henri I Doctoral candidate HUS, Hyvinkää Hospital
49 Leppälahti Suvi I Doctoral candidate UH, Faculty of Medicine
50 Luostarinen Tapio I Doctoral candidate UH, Faculty of Medicine
51 Lyytikäinen Erika I Doctoral candidate University of Oulu
52 Lönnberg Stefan I Doctoral candidate Finnish Cancer Registry
53 Mentula Maarit I Doctoral candidate UH, Faculty of Medicine
54 Merikukka Marko I Doctoral candidate University of Oulu
55 Männistö Jaana I Doctoral candidate University of Oulu
56 Niemi Suvi I Doctoral candidate UH, Faculty of Medicine
57 Parviainen Helka I Doctoral candidate UH, Faculty of Medicine
58 Pelkonen Sari I Doctoral candidate University of Oulu
59 Rahkola Päivi I Doctoral candidate UH, Faculty of Medicine
60 Riihimäki Outi I Doctoral candidate UH, Faculty of Medicine
61 Soini Tuuli I Doctoral candidate HUS, Hyvinkää Hospital
62 Suomalainen-König Sanna I Doctoral candidate Helsinki Univ Central Hosp
63 Sälevaara Mari I Doctoral candidate Family Federation of Finland
64 Tarjanne Satu I Doctoral candidate UH, Faculty of Medicine
65 Tommola Päivi I Doctoral candidate UH, Faculty of Medicine
66 Vattulainen Sanna I Doctoral candidate UH, Faculty of Medicine
67 Villa Pia I Doctoral candidate UH, Faculty of Medicine
68 Woodhall Sarah I Doctoral candidate University of Tampere
69 Öhman Hanna I Doctoral candidate University of Oulu
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Name of the RC’s responsible person: Paavonen, Jorma 
E-mail of the RC’s responsible person:   
Name and acronym of the participating RC: Women's Health Research Program, Women's Health 
The RC’s research represents the following key focus area of UH: 6. Kliininen tutkimus – Clinical research 
Comments for selecting/not selecting the key focus area:  
 
 
 Description of the RC’s research focus, the quality of the RC’s research (incl. key research 
questions and results) and the scientific significance of the RC’s research for the research 
field(s).  
The research focus is women’s health including large projects on infection, reproduction, tumours and 
genetics (Figure 1). Research on women’s health has evolved and expanded significantly dur-ing recent 
years. Our department is the largest department of obstetrics and gynecology in the whole Europe. 
Thus, the major strengths of the RC include huge base for clinical patient-oriented research, utilization 
of unique biobanks and health registry networks, large multidisciplinary re-search consortium, and 
integration of clinical research with basic research and translational re-search. Selected examples of he 
key research questions are:  
1. Defining key host factors of the immune response to C. trachomatis infection which is the main cause 
of  tubal factor infertility. What are the best immune response biomarkers predicting tubal damage 
caused by C. trachomatis.  
2. What is the efficacy and cost-effectiveness of HPV vaccination against high grade cervical, vagi-nal and 
vulvar precancer as defined in a large randomized trial. Our large community-randomized HPV 
vaccination trial will answer the questio of the best strategy of HPV vaccination from the pub-lic health 
point o view. Linking the registry of the vaccinated individuals and cancer registry of Finland will 
ultimately answer the question of the vaccine efficacy against invasive cervical cancer. 3. We want to 
test new biomarkers in predicting preterm birth. This is possible based on the clinical material of 
cervicovaginal samples of 6,000 pregnant women.  
4. Introducing HPV-DNA testing in primary screening for cervical cancer, to replace conventional Pap 
smear.  
5. Implementing elective single embryo transfer in routine IVF treatment, to avoid multiple preg-
nancies.  
6. What are the health effects of sex steroids in early or late postmenopausal hormone therapy. How to 
best optimize hormonal therapy.  
7. Implementation of medical pregnancy termination, to replace conventional surgical termination. 8. 
Pregnancy is a window to women’s health – is this a lost opportunity?  
9. Molecular epidemiology of breast cancer and ovarian cancer.  
10. In the pregnancy and genes project we want to focus in the genetics of the most common ob-stetric 
disorders, pre-eclampsia and gestational diabetes. 
 
BACKGROUND INFORMATION 
1 FOCUS AND QUALITY OF RC'S RESEARCH (MAX. 8800 CHARACTERS WITH SPACES) 
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RC-SPECIFIC STAGE 2 MATERIAL  
 
 
The scientific significance of research on women’s health has tremendously expanded during re-cent 
years. Some years ago women’s health research primarily focused on reproductive health only. The 
current broad concept has led to the recognition that research priorities in women’s health must be 
comprehensive and interdiciplinary and should include the full spectrum of research from clinical 
research to molecular and genetic research including prevention of important diseases and studies of 
outcomes of new interventions such as HPV vaccination. Research on reproduction has also expanded 
from menarche to the natural history of menopausal transition and focuses also on the interaction of 
hormones and environment and genetic susceptibility to significant malignan-cies such as ovarian 
cancer and breast cancer. 
Our goal is to meet these important challenges. We have been able to produce high impact re-search 
and specifically high impact clinical research in many fields of women’s health. Our produc-tivity has 
been strikingly high and of extremely high quality. This justifies us to look for international recognition 
through evaluation. 
 Ways to strengthen the focus and improve the quality of the RC’s research. 
The central theme of this research program is women’s health. The scientific goals of the program will 
be accomplished through extensive interaction between clinical and basic research. Our re-search 
program includes distinct interrelated projects established by experienced group leaders. The strong 
synergy and coalition between the programs has already been demonstrated by excel-lent track record 
in research productivity. We plan further strengthen the focus by increasing clini-cal patient oriented 
research and by increasingly utilizing biobanks and health registry networks. Our goal is to build a better 
physician-scientist career pipeline and motivate increasing number of young residents to do clinical and 
translational research. We are convinced that our RC will revital-ize the physician-scientist career 
through commitment to research training of residents and gradu-ate students. 
 
 
  How is doctoral training organised in the RC? Description of the RC’s principles for recruitment and 
selection of doctoral candidates, supervision of doctoral candidates, collaboration with faculties, 
departments/institutes, and potential graduate schools/doctoral programmes, good practises and 
quality assurance in doctoral training, and assuring good career perspectives for the doctoral 
candidates/fresh doctorates.  
We have already enrolled almost 50 residents and PhD students in the Women’s Health Program. 5-6 
doctoral candidates complete their PhD programs annually. The group leaders of the program are 
extremely effective in recruiting new doctoral candidates and have extensive experience in supervising 
doctoral candidates. We have established a clinical graduate school at our university by the 
Departments of Obstetrics and Gynecology and Pediatrics. Four positions are available for doctoral 
candidates. Large number of candidates have been seeking these positions. In addition doctoral 
candidates can seek appointment by the National Clinical Graduate School of Finland. Currently at least 
three doctoral candidates of the Women’s Health Program have been recruited in this graduate school. 
We have been organizing annually 2-3 research retreats for the doctoral can-didates, the last retreat 
took place February 3, 2011. There were seven scientific presentations by the doctoral candidates of the 
Women’s Health Program. Every doctoral candidate has at least two supervisors. In addition these 
candidates have an evaluation board with annual meetings in which the progress of the research is 
evaluated and further strengthened. 
 
 
2 PRACTISES AND QUALITY OF DOCTORAL TRAINING (MAX. 8800 CHARACTERS WITH SPACES) 
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 RC’s strengths and challenges related to the practises and quality of doctoral training, and the actions 
planned for their development. 
Strenghts: 
Large pool of residents and PhD students. 
Experienced academic chief investigators involved in undergraduate and postgraduate teaching and 
clinical bedside work. 
 
Challenges: 
Increase and improve the systematic structure of doctoral training. 
 
 
 Description of how the RC interacts with and contributes to the society (collaboration with public, 
private and/or 3rd sector).  
The several key research topics of the Women’s Health Program have major contribution to the society. 
For instance HPV vaccination, medical abortion, cervical cancer screening program, preg-nancy and 
genes research, and pregnancy – a health window project. Therefore this research community must 
interact and contribute to the society by translating research outcome into public health. Women’s 
Health Program also has extensive collaboration with many research institutes outside the university 
such as National Public Health Institute, Cancer Registry, Family Federation of Finland and also big 
pharma (GlaxoSmithKline, Sanofi Pasteur, MSD, Bayer-Schering). 
 Ways to strengthen the societal impact of the RC’s research and doctoral training. 




 Description of the RC’s research collaborations and joint doctoral training activities and how the RC 
has promoted researcher mobility.  
International collaboration has long and successful track record as can be seen from several major 
landmark publications in high impact journals during recent years. Women’s Health Program has 
international collaboration at global level (for example, HPV vaccination trials), European level (for 
example, EPIGEN Chlamydia Consortium), Scandinavian level (for example, biobank networking), and 
national level (such as research collaboration between the five ob/gyn university departments in 
Finland). Most group leaders have spent several years abroad in the best academic institutions and 
universities, and subsequently continued productive research collaboration. One of our col-laborators 
and supervisors recently received the Nobel Prize (Harald zur Hausen, Heidelberg, Ger-many). 
 RC’s strengths and challenges related to research collaboration and researcher mobility, and the 
actions planned for their development. 
The strengths are listed above. 
One challenge is to recruit more international junior and senior collaborators to the program on site in 
Helsinki. We have already invited one Visiting Professor from the Emory University, Atlanta (Prof. Kevin 
Ault) who is joining the program later this year. 
3 SOCIETAL IMPACT OF RESEARCH AND DOCTORAL TRAINING (MAX. 4400 CHARACTERS WITH SPACES) 
4 INTERNATIONAL AND NATIONAL (INCL. INTERSECTORAL) RESEARCH COLLABORATION AND RESEARCHER 
MOBILITY (MAX. 4400 CHARACTERS WITH SPACES) 
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Another challenge is to organize Master Class Symposia on different aspects of Women's Health and 
invite participants from other university clinics in Finland and also abroad. Our experience of two of such 




 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties).  
All senior group leaders of the Women’s Health Program have extensive teaching duties and par-ticipate 
both in undergraduate and postgraduate teaching. Many are also involved in bedside clini-cal work. This 
is extremely important since most important questions often arise bedside. Prof. Jorma Paavonen is the 
overall program leader (H-Index 50) and each major project has a group leader. Each project has several 
senior chief investigators. Overall, there are 10 senior investiga-tors who are in charge of the program. 
The group leaders have biannual investigators’ meetings. In addition, group leaders organize 2-3 
research retreats for doctoral candidates annually. This lead-ership and management strengthens 
collaboration and ensures high quality research. 
 RC’s strengths and challenges related to operational conditions, and the actions planned for their 
development. 
The major strength is that Women's Health program represents clinical research in the first place. 
Clinical research has exceptionally strong track record in Finland. 
The major challenge is how to translate the successful and productive program into better and 




 Description of the execution and processes of leadership in the RC, how the management-related 
responsibilities and roles are distributed in the RC and how the leadership- and management-related 
processes support high quality research, collaboration between principal investigators and other 
researchers in the RC, the RC’s research focus and strengthening of the RC’s know-how.  
These have been described above. 
 RC’s strengths and challenges related to leadership and management, and the actions planned for 
developing the processes. 
Strengths: 
Leadership under exceptionally experienced and productive senior investigators. 
Huge basis and potential for clinically oriented research. 
Wide spectrum of women’s health research. 
The home base is the largest OB/GYN Department in Europe providing unlimited research opportunities. 
Extensive networks, biobanks and health registries. 
Large pool of doctoral candidates. 
5 OPERATIONAL CONDITIONS (MAX. 4400 CHARACTERS WITH SPACES) 
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Senior investigators who also participate in undergraduate and postgraduate academic teaching and 
have clinical appointments at the University Hospital. 
 
Challenges: 
Challenge building a better physician-scientist pipeline revitalizing the physician-scientist career. 
Motivation of young residents to do clinical and translational research. 
Recruiting more post-doctoral fellows to be trained as the next generation of distinct research sci-
entists. 
Establishing a clinical trial center for patient-oriented research. 
Better office space for doctoral candidates. 




 Listing of the RCs external competitive funding, where: 
- the funding decisions have been made during 1.1.2005-31.12.2010, and 
- the administrator of the funding is/has been the University of Helsinki 
 
 Academy of Finland (AF) - total amount of funding (in euros) AF has decided to allocate to the RC 
members during 1.1.2005-31.12.2010: 1470000 
 
 Finnish Funding Agency for Technology and Innovation (TEKES) - total amount of funding (in euros) 
TEKES has decided to allocate to the RC members during 1.1.2005-31.12.2010: 270000 
 
 European Union (EU) - total amount of funding (in euros) EU has decided to allocate to the RC members 
during 1.1.2005-31.12.2010: 250000 
 
 European Research Council (ERC) - total amount of funding (in euros) ERC has decided to allocate to the 
RC members during 1.1.2005-31.12.2010:  
 
 International and national foundations – names of international and national foundations which have 
decided to allocate funding to the RC members during 1.1.2005-31.12.2010, and the amount of their 
funding (in euros).  
- names of the foundations: Cancer Society of Finland 
- Päivikki Solhberg Foundation 
- Juho Vainio Foundation 
- Yrjö Jahnsson Foundation 
- Antti and Jenny Wihuri Foundation 
- NFOG 
- Jane ja Aatos Erkko Foundation 
- The Finnish Medical Foundation 
- Nordic Cancer Union 
- Sigrid Juselius Foundation 
7 EXTERNAL COMPETITIVE FUNDING OF THE RC 
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- total amount of funding (in euros) from the above-mentioned foundations: 2120000 
 
 Other international funding - names of other international funding organizations which have decided to 
allocate funding to the RC members during 1.1.2005-31.12.2010, and the amount of their funding (in 
euros). 
- names of the funding organizations: Columbia University, USA 
- NHGRI, NIH, USA 
- total amount of funding (in euros) from the above-mentioned funding organizations: 30000 
 
 Other national funding (incl. EVO funding and Ministry of Education and Culture funded doctoral 
programme positions) - names of other national funding organizations which have decided to allocate 
funding to the RC members during 1.1.2005-31.12.2010, and the amount of their funding (in euros). 
- names of the funding organizations: EVO funding 
- Helsinki University funding 




 Description of the RC’s future perspectives in respect to research and doctoral training. 
First priority is to increase scientific productivity. The outlook is very promising. For instance the impact 
factors have constantly been over 350 and we are confident that this trend continues. Also the total 




All chief investigators have provided complete CV's including information required for TUHAT database. 
8 RC’S STRATEGIC ACTION PLAN FOR 2011–2013 (MAX. 4400 CHARACTERS WITH SPACES) 
9 SHORT DESCRIPTION OF HOW THE RC MEMBERS HAVE CONTRIBUTED TO THE COMPILATION OF THE STAGE 2 
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1 Analysis of publications 
 
- Associated person is one of Jorma Paavonen ,  Ralf Butzow ,  Markku Heikinheimo , 
Oskari Heikinheimo ,  Hannele Maaret Laivuori ,  Tomi Sakari Mikkola , 
Heli Nevanlinna ,  Pekka Juhani Nieminen ,  Aila Tiitinen ,  
Olavi Ylikorkala ,  Noora Karoliina Andersson ,  Mikko Tapani Anttonen ,  Sanna 
Heino ,  Ritva Anneli Hurskainen , Päivi Irmeli Joki-Korpela ,  Heini Lassus, Arto 
Leminen ,  Mikko Loukovaara ,  Mirja Puolakkainen ,  Jonna Salonen , 
 Hanna Maria Savolainen-Peltonen , Minna Tikkanen ,  Anastasia Kaisa Pauliina 
Tuomikoski ,  Leila Unkila-Kallio ,  Mervi Riitta Hannele Väisänen-Tommiska , mervi.vaisanen-
tommiska@helsinki.fi, Tia Aalto-Viljakainen ,  Anniina Färkkilä ,  Ulla-Maija Haltia (o.s. Silfverhuth) , ulla-
maija.  Hanna Hautamäki ,  Tuomas Heikkinen ,  Janina Charlotte Kaislasuo o.s. Hägglund 
,  Ilkka Elis Juhani Kalliala ,  Riitta Koivisto-Korander ,  Elina Pohjoranta o.s. 
Kuronen ,  Antti Kyrönlahti ,  Maarit Kristiina Leinonen , Henri Mikael Leminen , 
 Suvi Leppälahti ,  Stefan Lönnberg ,  Maarit Mentula ,  Helka 
Parviainen ,  Päivi Rahkola ,  Päivi Tommola, Pia Maria Villa ,  
 
Publication year 
Publication type 2005 2006 2007 2008 2009 2010 
Total Count 2005 - 
2010 
A1 Refereed journal article 73 67 81 70 86 66 443 
A2 Review in scientific journal  1 4 6 3 2 16 
A3 Contribution to book/other compilations (refereed) 6 7 1 1   15 
A4 Article in conference publication (refereed)  2  2  3 7 
B1 Unrefereed journal article 14 18 7 5 4 12 60 
B2 Contribution to book/other compilations (non-refereed)     1 1 2 
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2 Listing of publications 
A1 Refereed journal article 
2005 
Aaltonen, L, Cajanus, S, Bäck, L, Nieminen, P, Paavonen, J, Ranki, A 2005, 'Extralaryngeal HPV infections in male patients with adult-
onset laryngeal papillomatosis', European Archives of Oto-Rhino-Laryngology, vol 262, no. 9, pp. 708-712. 
Antoniou, AC, Pharoah, PD, Narod, S, Risch, HA, Eyfjord, JE, Hopper, JL, Olsson, H, Johannsson, O, Borg, Å, Pasini, B, Radice, P, 
Eerola, H, Nevanlinna, H 2005, 'Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 
6174delT mutations: a combined analysis of 22 population based studies', Journal of Medical Genetics, vol 42, no. 7, pp. 602-603. 
Anttonen, MT, Unkila-Kallio, L, Leminen, A, Butzow, R, Heikinheimo, M 2005, 'High GATA-4 expression associates with aggressive 
behavior, whereas low anti-Mullerian hormone expression associates with growth potential of ovarian granulosa cell tumors',  Journal of 
Clinical Endocrinology and Metabolism, vol 90, no. 12, pp. 6529-6535. 
Auvinen, E, Niemi, M, Malm, C, Zilliacus, R, Trontti, A, Fingerroos, R, Lehtinen, M, Paavonen, J 2005, 'High prevalence of HPV among 
female students in Finland', Scandinavian Journal of Infectious Diseases, vol 37, no. 11/12, pp. 873-876. 
Badeau, M, Tikkanen, MJ, Appt, SE, Adlercreutz, H, Clarkson, TB, Hoikkala, A, Wähälä, K, Mikkola, TS 2005, 'Determination of plasma 
genistein fatty acid esters following administration of genistein or genistein 4'7-O-dioleate in monkeys',  Biochimica and Biophysica 
Acta. Molecular and Cell Biology of Lipids, vol 1738, pp. 115-120. 
Bielinska, M, Genova, E, Boime, I, Parviainen, H, Kiiveri, S, Rahman, N, Leppäluoto, N, Heikinheimo, M, Wilson, DB 2005, 'Nude mice 
as a model for gonadotropin-induced adrenocortical neoplasia',  Endocrine Research, vol 30, no. 4, pp. 913-917. 
Bielinska, M, Genova, E, Boime, I, Parviainen, H, Kiiveri, S, Leppäluoto, J, Rahman, N, Heikinheimo, M, Wilson, DB 2005, 
'Gonadotropin-induced adrenocortical neoplasia in NU/J nude mice', Endocrinology, vol 146, no. 9, pp. 3975-3984. 
Catalano, RD, Critchley, HO, Heikinheimo, O, Smith, SK, Sharkey, AM 2005, 'Identification of novel progesterone receptor regulated 
pathways in the endometrium.', Journal of the Society for Gynecologic Investigation, vol 12, pp. 209-210. 
Eerola, H, Heikkilä, P, Tamminen, A, Aittomäki, K, Blomqvist, C, Nevanlinna, H 2005, 'Histopathological features of breast tumours in 
BRCA1, BRCA2 and mutation-negative breast cancer families',  Breast cancer research, vol 7, no. 1, pp. R93-R100. 
Eerola, H, Heikkilä, P, Tamminen, A, Aittomäki, K, Blomqvist, C, Nevanlinna, H 2005, 'Relationship of patients' age to histopathological 
features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families', Breast Cancer Research (Online 
Edition), vol 7. 
Erkinheimo, T, Sivula, A, Lassus, H, Heinonen, M, Furneaux, H, Haglund, C, Butzow, R, Ristimäki, A 2005, 'Cytoplasmic HuR 
expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma',  
Gynecologic Oncology, vol 99, no. 1, pp. 14-19. 
Heikinheimo, O 2005, 'Tarvitaanko kuukausittaista vuotoa?', Duodecim, vol 121, no. 3, pp. 245-247. 
Heikinheimo, O, Leminen, R, Raivio, T 2005, 'Late follicular phase administration of mifepristone suppresses circulating leptin and 
follicle-stimulating hormone - Mechanism(s) of action in ovulation inhibition?', Journal of the Society for Gynecologic Investigation, 
vol 12, pp. 318-318. 
Honkanen, H, Ranta, S, Ylikorkala, O, Heikinheimo, O 2005, 'Effect of antiprogesterone mifepristone followed by misoprostol on 
circulating leptin in early pregnancy', Acta Obstetricia et Gynecologica Scandinavica, vol 84, no. 2, pp. 134-139. 
Honrado, E, Osorio, A, Palacios, J, Milne, RL, Sanchez, L, Diez, O, Cazorla, A, Syrjäkoski, K, Huntsman, D, Heikkilä, P, Lerma, E, 
Kallioniemi, A, Rivas, C, Foulkes, WD, Nevanlinna, H, Benitez, J 2005, 'Immunohistochemical expression of DNA repair proteins in 
familial breast cancer differentiate BRCA2-associated tumors', Journal of Clinical Oncology, vol 23, no. 30, pp. 7503-7511. 
Hyden-Granskog, C, Unkila-Kallio, L, Halttunen-Nieminen, M, Tiitinen, A 2005, 'Single embryo transfer is an option in frozen embryo 
transfer', Human Reproduction, vol 20, no. 10. 
Jacobsen, CM, Männistö, S, Porter-Tinge, S, Genova, E, Parviainen, H, Heikinheimo, M, Adameyko, II, Tevosian, SG, Wilson, DB  2005, 
'GATA-4: FOG interactions regulate gastric epithelial development in the mouse', Developmental Dynamics, vol 234, no. 2, pp. 355-
362. 
Jokela, P, Joki-Korpela, P, Maaronen, M, Glumoff, V, Hyypiä, T 2005, 'Detection of human picornaviruses by multiplex reverse 
transcription-PCR and liquid hybridization', Journal of Clinical Microbiology, vol 43, no. 3, pp. 1239-1245. 
Joosten, SA, Smit van Dixhoorn, MGA, Borrias, MC, van Ham, V, Groot Koerkamp, MJA, Savolainen-Peltonen, H, Häyry, P, Daha, MR, 
van Kooten, C, Paul, LC 2005, 'Genetic profiling of aortic allografts: prothymosin alpha as potential target?', Transplant International, 
vol 18, no. 8, pp. 1010-1015. 
Kajantie, E, Kaaja, R, Ylikorkala, O, Andersson, S, Laivuori, H 2005, 'Adiponectin concentrations in maternal serum: elevated in 
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Kalliala, I, Anttila, A, Pukkala, E, Nieminen, P 2005, 'Risk of cervical and other cancers after treatment of cervical intraepithelial 
neoplasia: retrospective cohort study', BMJ : British Medical Journal, vol 331, no. 7526, pp. 1183-1185. 
Kalme, T, Seppälä, M, Qiao, Q, Koistinen, R, Nissinen, A, Harrela, M, Loukovaara, M, Leinonen, P, Tuomilehto, J 2005, 'Sex hormone-
binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in 
elderly men', Journal of Clinical Endocrinology and Metabolism, vol 90, no. 3, pp. 1550-1556. 
Kariola, R, Abdel-Rahman, WM, Ollikainen, M, Butzow, R, Peltomäki, P, Nyström, M  2005, 'APC and beta-catenin protein expression 
patterns in HNPCC-related endometrial and colorectal cancers',  Familial Cancer, vol 4, no. 2, pp. 187-190. 
Kiiveri, S, Liu, J, Arola, J, Heikkilä, P, Kuulasmaa, T, Lehtonen, E, Voutilainen, R, Heikinheimo, M, Lehtinen, E 2005, 'Transcription 
factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors', Molecular and Cellular Endocrinology, vol 233, pp. 47-
56. 
Kilpivaara, O, Bartkova, J, Eerola, H, Syrjäkoski, K, Vahteristo, P, Lukas, J, Blomqvist, C, Holli, K, Heikkilä, P, Sauter, G, Kallioniemi, O, 
Bartek, J, Nevanlinna, H 2005, 'Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics 
among unselected breast cancer patients', International Journal of Cancer, vol 113, no. 4, pp. 575-580. 
Kiuru, MHT, Lehtonen, R, Eerola, H, Aittomäki, K, Blomqvist, C, Nevanlinna, H, Aaltonen, LA, Launonen, V 2005, 'No germline FH 
mutations in familial breast cancer patients', European Journal of Human Genetics, vol 13, no. 4, pp. 506-509. 
Komi, J, Lankinen, KS, Härkönen, P, DeGregorio, MW, Voipio, S, Kivinen, S, Tuimala, R, Vihtamäki, T, Vihko, K, Ylikorkala, O, Erkkola, 
R 2005, 'Effects of ospemifene and raloxifene on hormonal status, lipids, genital tract, and tolerability in postmenopausal women', 
Menopause, vol 12, no. 2, pp. 202-209. 
Kotaniemi-Talonen, L, Nieminen, P, Anttila, A, Hakama, M 2005, 'Routine cervical screening with primary HPV testing and cytology 
triage protocol in a randomised setting', British Journal of Cancer, vol 93, no. 8, pp. 862-867. 
Kuokkanen, M, Butzow, R, Rasinperä, H, Medrek, K, Nilbert, M, Malander, S, Lubinski, J, Järvelä, I 2005, 'Lactase persistence and 
ovarian carcinoma risk in Finland, Poland and Sweden', International Journal of Cancer, vol 117, no. 1, pp. 90-94. 
Kupari, M, Mikkola, TS, Turto, H, Lommi, J 2005, 'Is the pregnancy hormone relaxin an important player in human heart failure?', 
European Journal of Heart Failure, vol 7, no. 2, pp. 195-198. 
Lehtovirta, P, Skogberg, K, Salo, E, Ämmälä, P, Ristola, M, Suni, J, Paavonen, J, Heikinheimo, O  2005, 'Pregnancy outcome among 
HIV-infected women in the Helsinki metropolitan area', Acta Obstetricia et Gynecologica Scandinavica, vol 84, no. 10, pp. 945-950. 
Leminen, R, Raivio, T, Ranta, S, Oehler, J, Hertzen, HV, Jänne, O, Heikinheimo, O  2005, 'Late follicular phase administration of 
mifepristone suppresses circulating leptin and FSH - mechanism(s) of action in emergency contraception?',  European Journal of 
Endocrinology, vol 152, pp. 411-418. 
Lempinen, M, Paju, A, Kemppainen, E, Smura, T, Kylänpää, M, Nevanlinna, H, Stenman, J, Stenman, UH  2005, 'Mutations N34S and 
P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: a report from Finland',  
Scandinavian Journal of Gastroenterology, vol 40, no. 2, pp. 225-230. 
Loukovaara, S, Immonen, I, Koistinen, R, Rutanen, E, Hiilesmaa, V, Loukovaara, M, Kaaja, R  2005, 'The insulin-like growth factor 
system and Type 1 diabetic retinopathy during pregnancy',  Journal of Diabetes and its Complications, vol 19, no. 5, pp. 297-304. 
Loukovaara, M, Pukkala, E, Lehtovirta, P, Leminen, A 2005, 'Epidemiology of hydatidiform mole in Finland, 1975 to 2001', European 
Journal of Gynecological Oncology, vol 26, no. 2, pp. 207-208. 
Loukovaara, M, Leinonen, P, Teramo, K, Andersson, S 2005, 'Concentration of cord serum placenta growth factor in normal and 
diabetic pregnancies', BJOG, vol 112, no. 1, pp. 75-79. 
Loukovaara, M, Loukovaara, S, Leinonen, P, Teramo, K, Andersson, S 2005, 'Endothelium-derived nitric oxide metabolites and soluble 
intercellular adhesion molecule-1 in diabetic and normal pregnancies',  European Journal of Obstetrics, and Gynecology ,and 
Reproductive Biology, vol 118, no. 2, pp. 160-165. 
Loukovaara, M, Leinonen, P, Teramo, K, Nurminen, E, Andersson, S, Rutanen, E 2005, 'Effect of maternal diabetes on phosphorylation 
of insulin-like growth factor binding protein-1 in cord serum', Diabetic Medicine, vol 22, pp. 434-439. 
Mikkola, T, Ylikorkala, O 2005, 'Hormone therapy and cardiovascular disease - still much to be learnt', Gynecological Endocrinology, 
vol 20, no. 2, pp. 116-120. 
Monto, K, Nieminen, P 2005, 'Gynekologisten irtosolunäytteiden määrät ja raportointitavat Suomessa',  Suomen lääkärilehti . 
Munsterhjelm, E, Munsterhjelm, N, Niemi, T, Ylikorkala, O, Neuvonen, PJ, Rosenberg, PH  2005, 'Dose-dependent inhibition of platelet 
function by acetaminophen in healthy volunteers', Anesthesiology, vol 103, no. 4, pp. 712-717. 
Munsterhjelm, E, Niemi, T, Ylikorkala, O, Silvanto, M, Rosenberg, PH  2005, 'Characterization of inhibition of platelet function by 
paracetamol and its interaction with diclofenac in vitro', Acta Anaesthesiologica Scandinavica, vol 49, no. 6, pp. 840-846. 
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Männistö, S, Butzow, R, Salonen, J, Leminen, A, Heikinheimo, O, Heikinheimo, M 2005, 'Transcription factors GATA-4 and GATA-6, 
and their potential downstream effectors in ovarian germ cell tumors',  Tumor Biology, vol 26, no. 5, pp. 265-273. 
Määttä, M, Butzow, R, Luostarinen, J, Petäjäniemi, N, Pihlajaniemi, T, Salo, S, Miyazaki, K, Autio-Harmainen, H, Virtanen, I 2005, 
'Differential expression of laminin isoforms in ovarian epithelial carcinomas suggesting different origin and providing tools for differential 
diagnosis', Journal of Histochemistry and Cytochemistry, vol 53, no. 10, pp. 1293-1300. 
Nieminen, P, Kotaniemi, L, Hakama, M, Tarkkanen, J, Martikainen, J, Toivonen, T, Ikkala, J, Luostarinen, T, Anttila, A  2005, 'A 
randomised public-health trial on automation-assisted screening for cervical cancer in Finlan: performance with 470,000 invitations',  
International Journal of Cancer, vol 115, no. 2, pp. 307-311. 
Nikander, E, Rutanen, E, Nieminen, P, Wahlström, T, Ylikorkala, O, Tiitinen, A 2005, 'Lack of effect of isoflavonoids on the vagina and 
endometrium in postmenopausal women', Fertility and Sterility : official journal of the American Fertility Society , vol 83, no. 1, pp. 
137-142. 
Oittinen, J, Kurki, T, Kekki, M, Kuusisto, M, Pussinen, P, Vilkuna-Rautiainen, T, Nieminen, A, Asikainen, S, Paavonen, J 2005, 
'Periodontal disease and bacterial vaginosis increase the risk for adverse pregnancy outcome',  Infectious Diseases in Obstetrics and 
Gynecology, vol 13, no. 4, pp. 213-216. 
Ollikainen, M, Abdel-Rahman, WM, Moisio, A, Lindroos, A, Kariola, R, Järvelä, I, Pöyhönen, MH, Butzow, R, Peltomäki, P 2005, 
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Hurskainen, R 2005, 'Abnormal menstrual bleeding', Evidence-based medicine guidelines, Duodecim John Wiley & Sons, Helsinki, 
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- a polarized epithelial cell culture?', in Chlamydial Infections: Proceedings of the Twelth International Symposium on Human 








INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC TUHAT COMPILATIONS OF PUBLICATIONS DATA 2005-2010 
 
 
B1 Unrefereed journal article 
2005 
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double embryo-transfer', Evidence - Based Obstetrics & Gynaecology, vol 7, pp. 87-88. 
Ulander, V, Ylikorkala, O 2005, 'Alatiesynnytys on perätilassa hyvä vaihtoehto: tärkeintä on synnytystavan yksilöllinen valinta : 
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Heikinheimo, O 2008, 'Use of the LNG-IUS in women with pre-existing medical conditions: [review article]', Gynaecology forum., vol 
13, no. 1, pp. 16-19. 
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Puolakkainen, M 2009, 'Mycoplasma pneumoniae –infektiot', Lääkärin käsikirja, Duodecim. 
2010 
Puolakkainen, M, Paavonen, J 2010, 'Klamydiat', in K Hedman, T Heikkinen, P Huovinen, A Järvinen, S Meri, M Vaara (eds), 
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D1 Article in professional journal 
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1 Analysis of activities 2005-2010 
 
- Associated person is one of Jorma Paavonen ,  Ralf Butzow ,  Markku Heikinheimo , 
Oskari Heikinheimo ,  Hannele Maaret Laivuori ,  Tomi Sakari Mikkola , 
Heli Nevanlinna ,  Pekka Juhani Nieminen ,  Aila Tiitinen ,  
Olavi Ylikorkala ,  Noora Karoliina Andersson ,  Mikko Tapani Anttonen ,  , 
 Sanna Heino , Ritva Anneli Hurskainen ,  Päivi Irmeli Joki-Korpela , Paivi.Joki-
 Heini Lassus, Arto Leminen ,  Mikko Loukovaara ,  Mirja Puolakkainen , 
 Jonna Salonen ,  , Hanna Maria Savolainen-Peltonen , 
 Minna Tikkanen ,  Anastasia Kaisa Pauliina Tuomikoski ,  Leila Unkila-Kallio , 
 Mervi Riitta Hannele Väisänen-Tommiska ,  Tia Aalto-Viljakainen ,  
Anniina Färkkilä ,  Ulla-Maija Haltia (o.s. Silfverhuth) ,  Hanna Hautamäki ,  
Tuomas Heikkinen ,  Janina Charlotte Kaislasuo o.s. Hägglund , Ilkka Elis Juhani Kalliala , 
Riitta Koivisto-Korander , Elina Pohjoranta o.s. Kuronen ,  Antti Kyrönlahti , 
 Maarit Kristiina Leinonen , Henri Mikael Leminen ,  Suvi Leppälahti , 
Stefan Lönnberg ,  Maarit Mentula ,  Helka Parviainen ,  
Päivi Rahkola ,  Päivi Tommola, Pia Maria Villa ,  
 
Activity type Count 
Supervisor or co-supervisor of doctoral thesis 27 
Prizes and awards 1 
Editor of research journal 51 
Peer review of manuscripts 24 
Assessment of candidates for academic posts 2 
Membership or other role in research network 6 
Membership or other role in national/international committee, council, board 33 
Membership or other role in public Finnish or international organization 17 
Membership or other role of body in private company/organisation 10 
Participation in interview for written media 4 
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2 Listing of activities 2005-2010 
Supervisor or co-supervisor of doctoral thesis 
Jorma Paavonen ,  
Supervision of MD thesis / Halmesmäki Karoliina, Jorma Paavonen, 2007, Finland 
Supervision of MD thesis / Lehtovirta Päivi, Jorma Paavonen, 2007, Finland 
Supervision of MD thesis / Tikkanen Minna, Jorma Paavonen, 2008, Finland 
Supervision of MD thesis / Jakobsson Maija, Jorma Paavonen, 2009, Finland 
Superivision of MD thesis / Lyytikäinen Erika, Jorma Paavonen, 2010, Finland 
Supervision of MD thesis / Rahkonen Leena, Jorma Paavonen, 2010, Finland 
Oskari Heikinheimo ,  
Supervision of MD thesis / Lehtovirta Päivi, Oskari Heikinheimo, 12.10.2007, Finland 
Hannele Maaret Laivuori ,  
Supervision of PhD thesis / Peterson Hanna, Hannele Maaret Laivuori, 01.01.2005  16.01.2010, Sweden 
Supervision of MD Thesis / Villa Pia, Hannele Maaret Laivuori, 18.09.2007  …, Finland 
Supervision of MD Thesis / Aalto-Viljakainen Tia, Hannele Maaret Laivuori, 2008  …, Finland 
Supervision of PhD Thesis / Sandbacka Maria, Hannele Maaret Laivuori, 29.05.2009  …, Finland 
Supervision of MD Thesis / Klemetti Miira, Hannele Maaret Laivuori, 2010  …, Finland 
Heli Nevanlinna ,  
Supervisor of PhD thesis / Eerola Hannaleena, Heli Nevanlinna, 2001  …, Finland 
Supervisor of PhD thesis / Vehmanen Paula, Heli Nevanlinna, 2001  …, Finland 
Supervisor of PhD thesis / Sarantaus Laura, Heli Nevanlinna, 2002  …, Finland 
Supervisor of PhD thesis / Vahteristo Pia, Heli Nevanlinna, 2003  …, Finland 
Supervisor of PhD thesis / Kilpivaara Outi, Heli Nevanlinna, 2007  …, Finland 
Supervisor of PhD thesis / Aaltonen Kirsimari, Heli Nevanlinna, 2008  …, Finland 
Supervisor of PhD thesis / Tommiska Johanna, Heli Nevanlinna, 2008  …, Finland 
Pekka Juhani Nieminen ,  
Supervisor of doctoral thesis / Kotaniemi-Talonen Laura, Pekka Juhani Nieminen, 2009 
Supervisor of doctoral thesis / Kalliala Ilkka, Pekka Juhani Nieminen, 2010 
Aila Tiitinen ,  
Supervisor of doctoral dissertation / Eviö Sirpa, Aila Tiitinen, 2006 
Supervisor of doctoral dissertation / Poikkeus Piia, Aila Tiitinen, 2007 
Mirja Puolakkainen ,  
Supervisor: Transcriptional analysis of persistent Chlamydia pneumoniae infection in vitro, Mirja Puolakkainen, 2000  2011 
Supervisor: CD8+ T cell response in experimental Chlamydia pneumoniae infection, Mirja Puolakkainen, 2005 
Ongoing PhD supervision: Juha Korhonen, Mirja Puolakkainen, 2007  … 
Ongoing PhD supervision: Suvi Niemi, Mirja Puolakkainen, 2009  … 
Prizes and awards 
Olavi Ylikorkala ,  
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Editor of research journal 
Jorma Paavonen ,  
Editorial Board Member, Sexually Transmitted Diseases (USA), Jorma Paavonen, 1990  …, United States 
Sexually Transmitted Diseases, Jorma Paavonen, 01.01.1990  … 
Editorial Board Member, Infectious Diseases of Obstetrics and Gynecology (USA), Jorma Paavonen, 1994  …, United States 
Associate Editor, Sexually Transmitted Infections (Genitourinary Medicine), UK, Jorma Paavonen, 1996  …, United Kingdom 
Editorial Board Member, International Journal of STD &amp; AIDS (UK), Jorma Paavonen, 1996  …, United Kingdom 
International Journal of STD &amp; AIDS, Jorma Paavonen, 01.01.1996  …, United Kingdom 
Sexually Transmitted Infections, Jorma Paavonen, 01.01.1996  … 
Acta Obstetricia et Gynecologica Skandinavica, Jorma Paavonen, 01.01.1999  …, Denmark 
APMIS, Jorma Paavonen, 01.01.2004  31.12.2005 
European Journal of Obstetrics &amp; Gynecology and Reproductive Biology, Jorma Paavonen, 01.01.2004  31.12.2005 
Clinical infectious diseases, Jorma Paavonen, 01.01.2005  31.12.2005 
Expert Review of Anti-infective Therapy, Jorma Paavonen, 01.01.2005  31.12.2005 
Suomen Lääkärilehti, Jorma Paavonen, 01.01.2005  31.12.2005 
Associate Editor, Acta Obstet Gynecol Scand (UK), Jorma Paavonen, 2010  …, United Kingdom 
Markku Heikinheimo ,  
Annals of Medicine, Markku Heikinheimo, 01.01.2003  31.12.2011, Finland 
Annals of Medicine, Markku Heikinheimo, 01.01.2006  31.12.2006, Finland 
Endocrinology Journal of Clinical Endocrinology and Metabolism, Markku Heikinheimo, 01.01.2006  31.12.2006, United States 
Endocrinology and Journal of Clinical Endocrinology and Metabolism, Markku Heikinheimo, 01.01.2006  31.12.2011, United States 
Oskari Heikinheimo ,  
European J of Contraception and Reproductive Health Care, Oskari Heikinheimo, 01.01.2005  31.12.2005 
Human Reproduction, Oskari Heikinheimo, 01.01.2005  31.12.2005 
Scandinavian J of Obstet Gyn, Oskari Heikinheimo, 01.01.2005  31.12.2005 
Heli Nevanlinna ,  
International Journal of Cancer, Heli Nevanlinna, 01.01.2003  31.12.2005 
Breast Cancer Research, Heli Nevanlinna, 01.01.2004  31.12.2005 
Human Molecular Genetics, Heli Nevanlinna, 01.01.2004  31.12.2005 
British Journal of Cancer, Heli Nevanlinna, 01.01.2005  31.12.2005 
Clinical Genetics, Heli Nevanlinna, 01.01.2005  31.12.2005 
Journal of Medical Genetics, Heli Nevanlinna, 01.01.2005  31.12.2005 
Pekka Juhani Nieminen ,  
Acta Obstetricia et Gynecologica Scandinavica, Pekka Juhani Nieminen, 1999  … 
Aila Tiitinen ,  
Acta Obstetricia et Gynecologica Scandinavica, Aila Tiitinen, 01.01.2000  …, Finland 
Duodecim, Aila Tiitinen, 2000  …, Finland 
Human Reproduction, Aila Tiitinen, 2000  … 
Molecular Human Reproduction, Aila Tiitinen, 2000  … 
European Journal of Obsterics, Gynaecology and Reprodductive Biology, Aila Tiitinen, 2004  … 
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Acta Obstetricia &amp; Gynecologica Scandinavica, Olavi Ylikorkala, 01.01.2005  31.12.2009 
American Journal of Obstetrics and Gynecology, Olavi Ylikorkala, 01.01.2005  31.12.2006 
Annals of Medicine, Olavi Ylikorkala, 01.01.2005  31.12.2005 
European Journal of Contraception, Olavi Ylikorkala, 01.01.2005  31.12.2006 
Fertility Sterility, Olavi Ylikorkala, 01.01.2005  31.12.2006 
Gynecological Endocrinology, Olavi Ylikorkala, 01.01.2005  31.12.2006 
Human Reproduction, Olavi Ylikorkala, 01.01.2005  31.12.2005 
Journal of Clinical Endocrinology &amp; Metabolism, Olavi Ylikorkala, 01.01.2005  31.12.2005 
Obstetrics and Gynecology, Olavi Ylikorkala, 01.01.2005  31.12.2006 
Annual of Medicine, Olavi Ylikorkala, 01.01.2006  31.12.2006 
Breast Cancer, Olavi Ylikorkala, 01.01.2006  31.12.2006 
Climacteric, Olavi Ylikorkala, 01.01.2006  31.12.2006 
Gynecological Medicine, Olavi Ylikorkala, 01.01.2006  31.12.2006 
Maturitas, Olavi Ylikorkala, 01.01.2006  31.12.2006 
Women¿s Health, Olavi Ylikorkala, 01.01.2006  31.12.2006 
Arto Leminen ,  
Acta Obstetricia et Gynaecologica Scandinavica, Arto Leminen, 01.01.2002  31.12.2005 
Suomen Lääkärilehti, Arto Leminen, 01.01.2004  31.12.2005 
Mikko Loukovaara ,  
Acta Obstetricia et Gynecologica Scandinavica, Mikko Loukovaara, 01.01.2005  31.12.2005 
Peer review of manuscripts 
Hannele Maaret Laivuori ,  
European Journal of Obstetrics &amp; Gyenecology and Reproductive Biology, Hannele Maaret Laivuori, 19.12.2003  … 
Human Molecular Genetics, Hannele Maaret Laivuori, 06.01.2003  … 
Acta Obstetricia et Gynecologica Scandinavia, Hannele Maaret Laivuori, 02.03.2004  … 
Acta Pediatrica, Hannele Maaret Laivuori, 27.12.2004  … 
Journal of Assisted Reproduction and Genetics, Hannele Maaret Laivuori, 02.02.2005  … 
Molecular Human Reproduction, European Society of Human Reproduction and Embryology, Hannele Maaret Laivuori, 28.03.2005  
…, United Kingdom 
Suomen Lääkärilehti, Hannele Maaret Laivuori, 21.08.2005  …, Finland 
American Journal of Obstetrics and Gynecology, Hannele Maaret Laivuori, 15.04.2006  …, United States 
Diabetes, Hannele Maaret Laivuori, 08.02.2006  …, United States 
Duodecim, Hannele Maaret Laivuori, 20.06.2006  …, Finland 
BMC Medical Genetics, Hannele Maaret Laivuori, 30.12.2007  … 
British Journal of Obstetrics and Gynaecology, Hannele Maaret Laivuori, 21.08.2007  … 
Human Genetics, Hannele Maaret Laivuori, 06.06.2007  … 
Human Reproduction, Hannele Maaret Laivuori, 12.09.2008  … 
The Journal of Obstetrics and Gynecology Research, Hannele Maaret Laivuori, 14.12.2008  … 
European Journal of Human Genetics, Hannele Maaret Laivuori, 28.06.2009  … 
Archives in Obstetrics ang Gynecology, Hannele Maaret Laivuori, 09.02.2010  … 
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Mirja Puolakkainen ,  
Referee, Mirja Puolakkainen, 2005 
Referee, Mirja Puolakkainen, 2006 
Referee, Mirja Puolakkainen, 2007 
Referee, Mirja Puolakkainen, 2008 
Referee, Mirja Puolakkainen, 2009 
Referee, Mirja Puolakkainen, 2010 
Assessment of candidates for academic posts 
Hannele Maaret Laivuori ,  
Assessment of candidate for the rank of scientist, Hannele Maaret Laivuori, 2009, United States 
Asessment of Candidate for Professor of Genetic Epidemiology and Biostatistics, Hannele Maaret Laivuori, 2010, Australia 
Membership or other role in research network 
Hannele Maaret Laivuori ,  
Member of study board, FINNPEC (The Finnish Genetics of Preeclampsia Consortium), Hannele Maaret Laivuori, 2007  …, Finland 
Member of study board, FinnGeDi (The Finnish Gestational Diabetes Study), Hannele Maaret Laivuori, 2009  …, Finland 
Member of study board, PREDO (Prediction and prevention of Pre-eclampsia), Hannele Maaret Laivuori, 2009  …, Finland 
Preeclampsia CoLaboratory Program, Hannele Maaret Laivuori, 09.10.2010  …, United States 
Pia Maria Villa ,  
Member of study board of PREDO (Prediction and prevention of pre-eclampsia), Pia Maria Villa, 2009  … 
Membership of ISSHP (International Society for the Study of Hypertension in Pregnancy), Pia Maria Villa, 2010  … 
Membership or other role in national/international committee, council, board 
Jorma Paavonen ,  
International Center for Reproductive Health, University of Ghent, Jorma Paavonen, 1995  …, Belgium 
FIGO Expert Advisory Panel on STDs, Gynecological Infections, Parasites &amp; HIV, Jorma Paavonen, 1997  … 
Cancer Organizations of Finland, Jorma Paavonen, 2005  …, Finland 
Biomedicum Helsinki, Steering committee member, Jorma Paavonen, 2007  …, Finland 
ESIDOG (European Society of Infectious Disease in Obstetrics and Gynecology, Jorma Paavonen, 2009  … 
Markku Heikinheimo ,  
Board for M.D.-Ph.D. Program, University of Helsinki, Markku Heikinheimo, 2006  2011, Finland 
Duodecim, Markku Heikinheimo, 01.01.2006  31.12.2011, Finland 
Lääkäriseura Duodecim, Markku Heikinheimo, 01.01.2006  31.12.2006, Finland 
Thesis Committee Board of the Faculty of Medicine, Markku Heikinheimo, 2007  2011, Finland 
Board for Research Funds, Helsinki University Central Hospital, Markku Heikinheimo, 2008  …, Finland 
Oskari Heikinheimo ,  
Raskaudenkeskeytys käypä hoito -ryhmä, Duodecim, Oskari Heikinheimo, 01.01.2005  31.12.2005, Finland 
Suomen Menopaussitutkimusseura, Oskari Heikinheimo, 01.01.2005  31.12.2005, Finland 
Hannele Maaret Laivuori ,  
Member of the International Council, International Society for the Study of Hypertension in Pregnancy (ISSHP), Hannele Maaret 
Laivuori, 2004  …, United Kingdom 
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Scientific officer of The Faculty of Medicine Research Council, Hannele Maaret Laivuori, 01.01.2009  …, Finland 
Secretary of the Finnish Society of Medical Genetics, Hannele Maaret Laivuori, 27.03.2009  19.03.2010, Finland 
Tomi Sakari Mikkola ,  
Finnish Menopause Society, President, Tomi Sakari Mikkola, 2009  …, Finland 
Helsingin yliopiston Lääketieteellisen tiedekunnan dosenttitoimikunnan jäsen, Tomi Sakari Mikkola, 2010  …, Finland 
Pekka Juhani Nieminen ,  
European Colposcopy Society, Pekka Juhani Nieminen, 2001  … 
Suomen Kolposkopiayhdistys ry., Pekka Juhani Nieminen, 2001  …, Finland 
Gynekologisen onkologian pienryhmä, Pekka Juhani Nieminen, 2005  …, Finland 
Aila Tiitinen ,  
International Federation of Fertility Societies, Aila Tiitinen, 2004  2007 
European Board and College of Obstetrics and Gynecology, Aila Tiitinen, 2010  … 
Olavi Ylikorkala ,  
European Society of Gynecology, vice-president, Congress President, tieteellisen järjestelytoimikunnan puheenjohtaja, Olavi Ylikorkala, 
01.01.2005  31.12.2005 
European Society of Gynecology, Olavi Ylikorkala, 01.01.2006  31.12.2006 
Gynecological Endocrine Society, Olavi Ylikorkala, 01.01.2006  31.12.2006 
Arto Leminen ,  
Naistentautien eettinen toimikunta, Arto Leminen, 01.01.2005  31.12.2005, Finland 
Mirja Puolakkainen ,  
American Society for Microbiology, Mirja Puolakkainen, 1992  …, United States 
HUS-piirin Koordinoiva Eettinen toimikunta, Mirja Puolakkainen, 2005  … 
European Society for Chlamydial Research, Mirja Puolakkainen, 2006  … 
Kliiniset Mikrobiologit ry, Mirja Puolakkainen, 2006  … 
Suomen Kliiniset Mikrobiologit, Mirja Puolakkainen, 2006  … 
Update on current care guidelines: Diagnosis and treatment of sexually transmitted infections, Mirja Puolakkainen, 2009  2010 
Membership or other role in public Finnish or international organization 
Markku Heikinheimo ,  
Ministry of Social Affairs and Health, Markku Heikinheimo, 01.03.2006  31.12.2011, Finland 
Sosiaali- ja Terveysministeriö (EVO-uudistusta valmistelevassa STMn toimikunnassa), Markku Heikinheimo, 01.01.2006  31.12.2006, 
Finland 
Oskari Heikinheimo ,  
Schering Advisory Board, Oskari Heikinheimo, 01.01.2005  31.12.2005, Finland 
Schering International Advisory Board, Oskari Heikinheimo, 01.01.2005  31.12.2005 
Hannele Maaret Laivuori ,  
Finnish Office for Health Technology Assessment:to plan and implement a national training programme with a view to harmonising 
prenatal screening practices., Hannele Maaret Laivuori, 20.12.2007  31.12.2010, Finland 
VALVIRA, Hannele Maaret Laivuori, 01.06.2009  …, Finland 
Pekka Juhani Nieminen ,  
STAKES, Pekka Juhani Nieminen, 2002  … 
Aila Tiitinen ,  
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Olavi Ylikorkala ,  
Biphosphanates for Gynecology, Expert Group Meeting in Berlin, Olavi Ylikorkala, 01.01.2005  31.12.2005 
Choice Investigators Follow-up Group, Meetings in Rome and Vienna, Olavi Ylikorkala, 01.01.2005  31.12.2005 
Drospireno Expert Group Meeting in Paris, Olavi Ylikorkala, 01.01.2005  31.12.2005 
Instrumentariumin tutkimussäätiö, Olavi Ylikorkala, 01.01.2005  31.12.2005 
Novartis Oy:n kansainvälinen Board: luento: Controversies on HRT: where we are now?, Olavi Ylikorkala, 01.01.2005  31.12.2005 
Helsingin yliopiston tutkimusapurahojen jakotoimikunta, Olavi Ylikorkala, 01.01.2006  31.12.2006, Finland 
Instrumentariumin tiedesäätiö, Olavi Ylikorkala, 01.01.2006  31.12.2006, Finland 
Kelan sos.lääketiet. neuvottelukunta, Olavi Ylikorkala, 01.01.2006  31.12.2006, Finland 
Mikko Loukovaara ,  
HUS:n eettinen toimikunta: Naistentautien ja synnytysten, korva- ja silmätautien, neurologian ja neurokirurgian eettisen toimikunnan 
varajäsen, Mikko Loukovaara, 01.01.2005  31.12.2005, Finland 
Membership or other role of body in private company/organisation 
Markku Heikinheimo ,  
Nordic Society for Paediatric Hematology and Oncology (NOPHO), Markku Heikinheimo, 01.01.2006  31.12.2011, Sweden 
Nordic Society for Pediatric Hematology and Oncology(NOPHO), Markku Heikinheimo, 01.01.2006  31.12.2006, Finland 
Oskari Heikinheimo ,  
Duodecim seura, vaalivaliokunnan jäsen, Oskari Heikinheimo, 01.01.2005  31.12.2005, Finland 
Duodecim seura, valtuuskunnan jäsen, Oskari Heikinheimo, 01.01.2005  31.12.2005, Finland 
Pekka Juhani Nieminen ,  
Suomen kliinisen sytologian yhdistys, Pekka Juhani Nieminen, 2001  … 
Aila Tiitinen ,  
Suomen Gynekologiyhdistys, pientyöryhmä, Aila Tiitinen, 1995  2008, Finland 
Suomen Gynekologiyhdistys, hallitus, Aila Tiitinen, 2002  …, Finland 
Suomen Gynekologiyhdistys, hallituksen puheenjohtaja, Aila Tiitinen, 2009  …, Finland 
Suomen Gynekologiyhdistyksen puheenjohtaja, Aila Tiitinen, 2010  2011, Finland 
Arto Leminen ,  
Etelä-Suomen Syöpäyhdistys, Arto Leminen, 01.01.2005  31.12.2005, Finland 
Participation in interview for written media 
Oskari Heikinheimo ,  
Suomen Kuvalehden artikkelin asiantuntija, Oskari Heikinheimo, 2006, Finland 
Olavi Ylikorkala ,  
Eurooppalainen Gynekologikongressi (SEG 2005) 3.6.2005, Olavi Ylikorkala, 03.06.2005, Finland 
Yleisöluento 8.3.2005, Olavi Ylikorkala, 08.03.2006, Finland 
Mirja Puolakkainen ,  
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Participation in TV programme 
Jorma Paavonen ,  
TV-ohjelma 17.7.2002, Jorma Paavonen, 02.06.2006, United States 
Aila Tiitinen ,  
Useita lehti-, radio- ja TV-haastatteluja. Luentoja lääketieteen toimittajille, luentoja yleisötilaisuuksissa (Sydänpäivä, Migreeniyhdistys 
jne). Hyvä terveys -lehden toimituskunta, useampiakin kirjoituksia ko lehdessä, Aila Tiitinen, 2003  …, Finland 
Olavi Ylikorkala ,  
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Web of Science(WoS)-based bibliometrics of the RC’s publications data 1.1.2005-31.12.2010  
by CWTS, Leiden University, the Netherlands 
Research Group: Paavonen J 
Basic statistics 
Number of publications (P) 406 
Number of citations (TCS) 5,056 
Number of citations per publication (MCS)  12.66 
Percentage of uncited publications 22% 
Field-normalized number of citations per publication (MNCS)   1.83 
Field-normalized average journal impact (MNJS)   1.43 
Field-normalized proportion highly cited publications (top 10%)   1.90 
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